Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Here you can find a discussion of the benefits offered by Pradaxa® for stroke prevention in patients with atrial fibrillation. Click here to learn more.
How do I treat mild to moderate renal impairment with Pradaxa®
Watch experts discuss how to calculate the renal function of the patients and the appropriate use of Pradaxa® in patients. Click here to watch the video.